Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02629614
Other study ID # ET-03
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 2016
Est. completion date November 2016

Study information

Verified date June 2023
Source Cala Health, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the safety and effectiveness of the Cala ONE device to aid in the symptomatic relief of hand tremors in adult essential tremor subjects. This study is a prospective, randomized, double-blinded, sham-controlled study.


Recruitment information / eligibility

Status Completed
Enrollment 93
Est. completion date November 2016
Est. primary completion date November 2016
Accepts healthy volunteers No
Gender All
Age group 22 Years and older
Eligibility Inclusion Criteria: 1. 22 years or older 2. A diagnosis of essential tremor as confirmed from clinical history and examination by a movement disorder neurologist 3. Signed informed consent 4. At least one hand exhibiting kinetic tremor = 2 as assessed by the TETRAS Archimedes spiral task completed during the baseline evaluation, as assessed by the Investigator in-person. 5. Score of 3 or above in any one of the items of the Bain & Findley ADL Scale Exclusion Criteria: 1. Implanted electrical medical device, such as a pacemaker, defibrillator, or deep brain stimulator 2. Previous thalamotomy procedure, including Stereotactic Thalamotomy, Gamma Knife Radiosurgical Thalamotomy, and focused ultrasound, for the treatment of tremor 3. Suspected or diagnosed epilepsy or other seizure disorder 4. Pregnant 5. Swollen, infected, inflamed areas, or skin eruptions, open wounds, or cancerous lesions of skin at stimulation site 6. Peripheral neuropathy affecting the tested upper extremity 7. Alcoholism (score of 4 or higher on DSM-5) 8. Other possible causes of tremor, including Parkinson's disease, drug-induced, enhanced physiological tremor, dystonia 9. Other neurodegenerative disease like Parkinson-plus syndromes suspected on neurological examination. These include: multisystem atrophy, progressive supranuclear palsy, dementia with Lewy bodies, and cortical basal ganglionic degeneration 10. Changes in medication for tremor within 1 month prior to study enrollment 11. Change in antidepressant medication within 3 months prior to study enrollment 12. Botulinum Toxin injection for hand tremor within 6 months prior to study enrollment 13. Current participation in any other interventional research study 14. Previous participation in any other Cala Health interventional research study 15. Alcohol or caffeine consumption within 12 hours of study enrollment Subjects already taking medications for their essential tremor will remain on their medications during the study with no changes in medication type or dosage levels.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Cala ONE Device
The Cala ONE device is a wrist-worn stimulator which applies transcutaneous electrical stimulation non-invasively to the median and radial nerves of an individual through disposable hydrogel electrodes.

Locations

Country Name City State
United States Kansas University Medical Center Kansas City Kansas
United States UCSF San Francisco California
United States Swedish Medical Center Seattle Seattle Washington
United States The Parkinson's Institute Sunnyvale California

Sponsors (1)

Lead Sponsor Collaborator
Cala Health, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Change in Kinetic Tremor The change in tremor severity on the kinetic tremor task as assessed by an investigator using the TETRAS rating scale.
The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.
Immediately before and after 40 minute stimulation session
Other Change in Kinetic Tremor The change in tremor severity on the kinetic tremor task as assessed by an investigator using the TETRAS rating scale.
The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.
Immediately before and 30 minutes into stimulation session
Other Change in Lateral "Wing Beating" Postural Tremor The change in tremor severity in the lateral "wing beating" postural tremor task as assessed by an investigator using the TETRAS rating scale.
The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.
Immediately before and after 40 minute stimulation session
Other Change in Lateral "Wing Beating" Postural Tremor The change in tremor severity in the lateral "wing beating" postural tremor task as assessed by an investigator using the TETRAS rating scale.
The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.
Immediately before and 30 minutes into stimulation session
Other Change in Forward Outstretched Postural Tremor The change in tremor severity on outstretched tremor task as assessed by an investigator using the TETRAS rating scale.
The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.
Immediately before and after 40 minute stimulation session
Other Change in Forward Outstretched Postural Tremor The change in tremor severity on outstretched tremor task as assessed by an investigator using the TETRAS rating scale.
The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.
Immediately before and 30 minutes into stimulation session
Other Change in Bain & Findley ADL: Use a Spoon to Drink Liquid The change in tremor severity on drinking liquid with a spoon as assessed by the subject using the Bain & Findley ADL rating scale.
The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.
Immediately before and after 40 minute stimulation session
Other Change in Bain & Findley ADL: Hold a Cup of Liquid The change in tremor severity on holding a cup of liquid as assessed by the subject using the Bain & Findley ADL rating scale.
The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.
Immediately before and after 40 minute stimulation session
Other Change in Bain & Findley ADL: Pouring The change in tremor severity on pouring as assessed by the subject using the Bain & Findley ADL rating scale.
The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.
Immediately before and after 40 minute stimulation session
Other Change in Bain & Findley ADL: Dialing The change in tremor severity on dialing a telephone as assessed by the subject using the Bain & Findley ADL rating scale.
The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.
Immediately before and after 40 minute stimulation session
Other Change in Bain & Findley ADL: Picking up Change The change in tremor severity on picking up change as assessed by the subject using the Bain & Findley ADL rating scale.
The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.
Immediately before and after 40 minute stimulation session
Other Change in Bain & Findley ADL: Inserting Plug Into Socket The change in tremor severity on inserting a plug into a socket as assessed by the subject using the Bain & Findley ADL rating scale.
The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.
Immediately before and after 40 minute stimulation session
Other Change in Bain & Findley ADL: Unlocking The change in tremor severity on unlocking a lock with a key as assessed by the subject using the Bain & Findley ADL rating scale.
The Bain and Findley Activities of Daily Living (BF-ADL) assessment evaluates the subject's ability to perform a number of specific ADLs, measured before and after treatment. Each ADL is performed by the subject and self-rated on a scale of 1-4, with higher scores indicating greater difficulty in performing the task.
Immediately before and after 40 minute stimulation session
Primary Change in TETRAS Spiral Rating After Stimulation The primary effectiveness variable is the change in tremor severity immediately after the stimulation session compared to baseline (immediately prior to stimulation) as measured using the TETRAS Archimedes spiral task (assessed by 3 blinded raters).
The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.
Immediately before and after 40 minute stimulation session
Secondary Change in TETRAS Spiral Rating During Stimulation An additional analysis variable is the change in tremor severity during the stimulation session (30 minutes into stimulation session) compared to baseline (immediately prior to stimulation) as measured using the TETRAS Archimedes spiral task (assessed by 3 blinded raters).
The Essential Tremor Rating Assessment Scale (TETRAS) is a commonly used scale to assess and measure the severity of essential tremor. Each task was calculated individually on a 0-4 scale, with higher scores indicating more severe tremors.
Immediately before and 30 minutes into stimulation session
Secondary Self-report Improvement The percentage of subjects in the treatment group indicating improvement on the CGI-I Scale will be compared to the sham group. The Clinical Global Impression - Improvement (GGI-I) scale evaluates a clinician's rating of tremor improvement noted in the subject, as a result of the treatment. The scale ranges from 1 (very much improved) to 7 (very much worse). Immediately before and after 40 minute stimulation session
See also
  Status Clinical Trial Phase
Withdrawn NCT05381688 - VIM DBS Respiratory Modulation: N-of-1 Trial
Recruiting NCT05101161 - Neurofeedback Using Implanted Deep Brain Stimulation Electrodes N/A
Completed NCT02277106 - Evaluate SAGE-547 in Participants With Essential Tremor Phase 2
Recruiting NCT05769933 - Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
Terminated NCT02894567 - Evaluation of Directional Recording and Stimulation Using spiderSTN N/A
Terminated NCT02678429 - Atlas Predicted DBS Settings in Essential Tremor N/A
Completed NCT02523807 - Tremor Monitoring Device N/A
Active, not recruiting NCT02255929 - Gamma Knife Radiosurgery for Treatment of Essential Tremor N/A
Completed NCT01223144 - Decision-making and Emotion Recognition in Essential Tremor N/A
Completed NCT00906412 - Ventrointermediate Nucleus (VIM DBS) and Working Memory N/A
Recruiting NCT05214222 - Penpulimab Plus Chemotherapy With/Without Anlotinib for Patients With Advanced Esophageal Squamous Cell Carcinoma Phase 2
Completed NCT03051178 - Wearable Sensor for Responsive DBS for ET N/A
Recruiting NCT03795935 - Relief From Side Effects: Clinical Use of Electrodes With Direction N/A
Not yet recruiting NCT06036368 - Study to Evaluate Safety and Efficacy of Peroneal Transcutaneous NeuroModulation in Subjects With Parkinson's Disease and Essential Tremor N/A
Recruiting NCT05897775 - Coordinated Reset Deep Brain Stimulation for Essential Tremor Phase 1
Recruiting NCT05968976 - Multicentre RCT of Awake Versus Asleep Tractography Based DBS for ET N/A
Completed NCT06314139 - Tolerability and Efficacy of Continuous Theta-burst Stimulation for Essential Tremor: A Randomized Study. N/A
Recruiting NCT04501133 - Sensory-specific Peripheral Stimulation for Tremor Management N/A
Active, not recruiting NCT03560622 - Functional Neuroimaging Feedback for Focused Ultrasound Thalamotomy N/A
Completed NCT00368199 - Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes N/A